

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.35149247 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.35149247 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 7.35149247 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 7.35149247 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 7.35149247 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.35149247 |
| 7 | microglial cell activation (GO:0001774) | 7.08559751 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.67355955 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.37516337 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 6.18437767 |
| 11 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.84739169 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.09966538 |
| 13 | response to host immune response (GO:0052572) | 4.97446824 |
| 14 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.97446824 |
| 15 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.74934273 |
| 16 | positive regulation of interferon-alpha production (GO:0032727) | 4.73383485 |
| 17 | response to host (GO:0075136) | 4.73320703 |
| 18 | response to host defenses (GO:0052200) | 4.73320703 |
| 19 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.73320703 |
| 20 | macrophage activation (GO:0042116) | 4.66251951 |
| 21 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.61785618 |
| 22 | response to peptidoglycan (GO:0032494) | 4.56689828 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 4.53976804 |
| 24 | regulation of interferon-alpha production (GO:0032647) | 4.50669811 |
| 25 | negative regulation of granulocyte differentiation (GO:0030853) | 4.36591466 |
| 26 | myeloid cell activation involved in immune response (GO:0002275) | 4.35992024 |
| 27 | positive regulation of chemokine secretion (GO:0090197) | 4.34535772 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 4.18271424 |
| 29 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.11588613 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 4.05772496 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 4.03588814 |
| 32 | respiratory burst (GO:0045730) | 3.99125947 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.92033715 |
| 34 | cellular extravasation (GO:0045123) | 3.89746703 |
| 35 | positive regulation of B cell differentiation (GO:0045579) | 3.89189894 |
| 36 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.78643106 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.74399348 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.71897227 |
| 39 | I-kappaB phosphorylation (GO:0007252) | 3.68077762 |
| 40 | neutrophil mediated immunity (GO:0002446) | 3.63729287 |
| 41 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.59205640 |
| 42 | pinocytosis (GO:0006907) | 3.56866079 |
| 43 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.52637255 |
| 44 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.51513073 |
| 45 | detection of other organism (GO:0098543) | 3.47062031 |
| 46 | glycosphingolipid catabolic process (GO:0046479) | 3.46590243 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.45108757 |
| 48 | neutrophil activation (GO:0042119) | 3.40590935 |
| 49 | germinal center formation (GO:0002467) | 3.40190800 |
| 50 | regulation of antigen processing and presentation (GO:0002577) | 3.37663500 |
| 51 | positive regulation of interferon-beta production (GO:0032728) | 3.35224094 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 3.32738853 |
| 53 | positive thymic T cell selection (GO:0045059) | 3.32539185 |
| 54 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.32529089 |
| 55 | detection of bacterium (GO:0016045) | 3.32403461 |
| 56 | granulocyte activation (GO:0036230) | 3.32237512 |
| 57 | negative regulation of cell killing (GO:0031342) | 3.30414956 |
| 58 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.30414956 |
| 59 | response to protozoan (GO:0001562) | 3.28405041 |
| 60 | regulation of chemokine secretion (GO:0090196) | 3.27177035 |
| 61 | myeloid leukocyte activation (GO:0002274) | 3.24645495 |
| 62 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.23062087 |
| 63 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.22326589 |
| 64 | B cell receptor signaling pathway (GO:0050853) | 3.20543434 |
| 65 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.19902412 |
| 66 | hyaluronan catabolic process (GO:0030214) | 3.19454585 |
| 67 | purinergic receptor signaling pathway (GO:0035587) | 3.18291449 |
| 68 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.15291754 |
| 69 | negative regulation of interleukin-12 production (GO:0032695) | 3.15146689 |
| 70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.14541578 |
| 71 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.14540086 |
| 72 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.13512818 |
| 73 | regulation of mast cell activation (GO:0033003) | 3.12018453 |
| 74 | mast cell activation (GO:0045576) | 3.11579359 |
| 75 | leukocyte aggregation (GO:0070486) | 3.10629347 |
| 76 | superoxide anion generation (GO:0042554) | 3.09386470 |
| 77 | negative regulation of interleukin-6 production (GO:0032715) | 3.08660339 |
| 78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.06848043 |
| 79 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06217330 |
| 80 | negative regulation of T cell mediated immunity (GO:0002710) | 3.06011045 |
| 81 | glycolipid catabolic process (GO:0019377) | 3.05906944 |
| 82 | regulation of hypersensitivity (GO:0002883) | 3.04965971 |
| 83 | detection of external biotic stimulus (GO:0098581) | 3.04247745 |
| 84 | positive regulation of mast cell activation (GO:0033005) | 2.97493266 |
| 85 | regulation of B cell differentiation (GO:0045577) | 2.97027284 |
| 86 | negative regulation of interleukin-17 production (GO:0032700) | 2.95489556 |
| 87 | T-helper 1 type immune response (GO:0042088) | 2.94063374 |
| 88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93667114 |
| 89 | B cell homeostasis (GO:0001782) | 2.93573075 |
| 90 | B cell mediated immunity (GO:0019724) | 2.90276729 |
| 91 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.89821742 |
| 92 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.89610439 |
| 93 | tolerance induction (GO:0002507) | 2.88417758 |
| 94 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.86823411 |
| 95 | positive regulation of mast cell degranulation (GO:0043306) | 2.86823411 |
| 96 | ceramide catabolic process (GO:0046514) | 2.86385797 |
| 97 | cellular response to interferon-beta (GO:0035458) | 2.86127535 |
| 98 | T cell migration (GO:0072678) | 2.85921943 |
| 99 | leukocyte degranulation (GO:0043299) | 2.85638785 |
| 100 | detection of molecule of bacterial origin (GO:0032490) | 2.85025070 |
| 101 | phagocytosis, engulfment (GO:0006911) | 2.84607083 |
| 102 | leukocyte mediated cytotoxicity (GO:0001909) | 2.83614907 |
| 103 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.82955230 |
| 104 | detection of biotic stimulus (GO:0009595) | 2.81462342 |
| 105 | regulation of tolerance induction (GO:0002643) | 2.79834890 |
| 106 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79638052 |
| 107 | negative regulation of interleukin-1 production (GO:0032692) | 2.79340147 |
| 108 | myeloid dendritic cell activation (GO:0001773) | 2.78789586 |
| 109 | negative regulation of growth of symbiont in host (GO:0044130) | 2.78085155 |
| 110 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.78085155 |
| 111 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.78085155 |
| 112 | regulation of growth of symbiont in host (GO:0044126) | 2.78085155 |
| 113 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76493551 |
| 114 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.76057000 |
| 115 | negative thymic T cell selection (GO:0045060) | 2.75791640 |
| 116 | mature B cell differentiation involved in immune response (GO:0002313) | 2.75517870 |
| 117 | negative regulation of innate immune response (GO:0045824) | 2.75469442 |
| 118 | histamine secretion (GO:0001821) | 2.75036066 |
| 119 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.74367502 |
| 120 | myeloid leukocyte mediated immunity (GO:0002444) | 2.73998212 |
| 121 | regulation of leukocyte degranulation (GO:0043300) | 2.73465560 |
| 122 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.72899525 |
| 123 | regulation of T cell tolerance induction (GO:0002664) | 2.72827862 |
| 124 | regulation of mononuclear cell migration (GO:0071675) | 2.72731961 |
| 125 | regulation of interleukin-12 production (GO:0032655) | 2.71743509 |
| 126 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.71548019 |
| 127 | regulation of macrophage chemotaxis (GO:0010758) | 2.71274157 |
| 128 | positive regulation of leukocyte degranulation (GO:0043302) | 2.71199794 |
| 129 | negative regulation of B cell proliferation (GO:0030889) | 2.70078501 |
| 130 | cellular response to exogenous dsRNA (GO:0071360) | 2.69897352 |
| 131 | neutrophil chemotaxis (GO:0030593) | 2.69688761 |
| 132 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.69675485 |
| 133 | oligosaccharide catabolic process (GO:0009313) | 2.69226101 |
| 134 | G-protein coupled receptor internalization (GO:0002031) | 2.69116565 |
| 135 | cyclooxygenase pathway (GO:0019371) | 2.68978617 |
| 136 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.67927132 |
| 137 | negative regulation of mast cell activation (GO:0033004) | 2.67561194 |
| 138 | reactive oxygen species biosynthetic process (GO:1903409) | 2.66185118 |
| 139 | regulation of regulated secretory pathway (GO:1903305) | 2.65918485 |
| 140 | macrophage chemotaxis (GO:0048246) | 2.65292140 |
| 141 | monocyte chemotaxis (GO:0002548) | 2.64952944 |
| 142 | defense response to protozoan (GO:0042832) | 2.64411398 |
| 143 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.64177621 |
| 144 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.63236035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.47244905 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.69848939 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.43926626 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.98215725 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.71473741 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.79845102 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.79295987 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.75871929 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.57963799 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.51804047 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.43149330 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.16777766 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.08617303 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.01193587 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.86855874 |
| 16 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.84253064 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67569513 |
| 18 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.56103679 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.43870059 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.37685115 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.35486078 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.30104706 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.23113541 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.17108395 |
| 25 | PU_27001747_Chip-Seq_BMDM_Mouse | 2.04656053 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99782939 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97410396 |
| 28 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.97317282 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.97198935 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.96807466 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89897809 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.88301363 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.87421651 |
| 34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80763699 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75453543 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71833806 |
| 37 | * MYB_26560356_Chip-Seq_TH2_Human | 1.68813478 |
| 38 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.68354083 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61504887 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59811652 |
| 41 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.57260559 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.56209165 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.53243857 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50712060 |
| 45 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.49812165 |
| 46 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48971366 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.47384922 |
| 48 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.45905057 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.45555778 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43610168 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42111376 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.37353381 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36933378 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33905892 |
| 55 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.32732037 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32021722 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29551452 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28672233 |
| 59 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27240938 |
| 60 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26381898 |
| 61 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.25650932 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24008034 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22686637 |
| 64 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19810885 |
| 65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19473271 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16643967 |
| 67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16047402 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16023463 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15973411 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15864899 |
| 71 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.15001721 |
| 72 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14554070 |
| 73 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.13872600 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11752587 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11633061 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10011710 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.08736429 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07343256 |
| 79 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.03670263 |
| 80 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00491440 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97617697 |
| 82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97434916 |
| 83 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.96811601 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96572919 |
| 85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96280072 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96161980 |
| 87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95138270 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92888577 |
| 89 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.91458915 |
| 90 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.91249089 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90375665 |
| 92 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89852960 |
| 93 | * P300_27268052_Chip-Seq_Bcells_Human | 0.88931899 |
| 94 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88413906 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86745865 |
| 96 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84446068 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.82747130 |
| 98 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.82320929 |
| 99 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80745002 |
| 100 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.80284403 |
| 101 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78431120 |
| 102 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75238037 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75072438 |
| 104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.72844387 |
| 105 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.72837423 |
| 106 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.72209039 |
| 107 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.71729562 |
| 108 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.69766260 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.68226567 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.65463150 |
| 111 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.64930741 |
| 112 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.63490801 |
| 113 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.62788038 |
| 114 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.62714022 |
| 115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60700600 |
| 116 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.59604162 |
| 117 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.59446767 |
| 118 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.58791199 |
| 119 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.57852838 |
| 120 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.57783076 |
| 121 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.57713533 |
| 122 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56463394 |
| 123 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.55952744 |
| 124 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.55233707 |
| 125 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.54458986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.49497655 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.37645330 |
| 3 | MP0006082_CNS_inflammation | 3.74360775 |
| 4 | MP0003172_abnormal_lysosome_physiology | 3.61020209 |
| 5 | MP0002419_abnormal_innate_immunity | 3.22601066 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 3.20462891 |
| 7 | MP0003436_decreased_susceptibility_to | 3.10529438 |
| 8 | MP0005464_abnormal_platelet_physiology | 3.08432023 |
| 9 | MP0005671_abnormal_response_to | 3.04234322 |
| 10 | MP0000569_abnormal_digit_pigmentation | 3.03126248 |
| 11 | MP0003303_peritoneal_inflammation | 2.97503914 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.69703654 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.62701272 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.59364081 |
| 15 | MP0009785_altered_susceptibility_to | 2.46622283 |
| 16 | MP0005025_abnormal_response_to | 2.46467523 |
| 17 | MP0001800_abnormal_humoral_immune | 2.43971271 |
| 18 | MP0002723_abnormal_immune_serum | 2.39767001 |
| 19 | MP0003724_increased_susceptibility_to | 2.23925357 |
| 20 | MP0001819_abnormal_immune_cell | 2.21907376 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.20414398 |
| 22 | MP0001790_abnormal_immune_system | 2.15315461 |
| 23 | MP0005387_immune_system_phenotype | 2.15315461 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.12476462 |
| 25 | MP0003183_abnormal_peptide_metabolism | 2.11773477 |
| 26 | MP0003690_abnormal_glial_cell | 2.06944039 |
| 27 | MP0005174_abnormal_tail_pigmentation | 1.99772381 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.89277975 |
| 29 | MP0000685_abnormal_immune_system | 1.86907407 |
| 30 | MP0003075_altered_response_to | 1.80279354 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.72168301 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.68889931 |
| 33 | MP0001853_heart_inflammation | 1.68051142 |
| 34 | MP0000716_abnormal_immune_system | 1.65441766 |
| 35 | MP0004510_myositis | 1.62225364 |
| 36 | MP0000343_altered_response_to | 1.62117264 |
| 37 | MP0000015_abnormal_ear_pigmentation | 1.59758613 |
| 38 | MP0008469_abnormal_protein_level | 1.58776110 |
| 39 | MP0002398_abnormal_bone_marrow | 1.57747966 |
| 40 | MP0002405_respiratory_system_inflammati | 1.57518279 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.54817204 |
| 42 | MP0009840_abnormal_foam_cell | 1.44196088 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.43782783 |
| 44 | MP0009278_abnormal_bone_marrow | 1.42783429 |
| 45 | MP0008004_abnormal_stomach_pH | 1.41770242 |
| 46 | MP0005310_abnormal_salivary_gland | 1.38958822 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.38385694 |
| 48 | MP0001851_eye_inflammation | 1.36363938 |
| 49 | MP0002429_abnormal_blood_cell | 1.34844130 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.33882774 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.33882774 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.33822798 |
| 53 | MP0002722_abnormal_immune_system | 1.33310817 |
| 54 | MP0003806_abnormal_nucleotide_metabolis | 1.30954804 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.29718420 |
| 56 | MP0004947_skin_inflammation | 1.28222781 |
| 57 | MP0003828_pulmonary_edema | 1.27920797 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.25663412 |
| 59 | MP0005166_decreased_susceptibility_to | 1.25101701 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.19344035 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.15678862 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.15399791 |
| 63 | MP0000371_diluted_coat_color | 1.13393481 |
| 64 | MP0010307_abnormal_tumor_latency | 1.12414615 |
| 65 | MP0001873_stomach_inflammation | 1.11808585 |
| 66 | MP0002006_tumorigenesis | 1.11328746 |
| 67 | MP0003448_altered_tumor_morphology | 1.09986812 |
| 68 | MP0003045_fibrosis | 1.09907147 |
| 69 | MP0009764_decreased_sensitivity_to | 1.00770493 |
| 70 | MP0002139_abnormal_hepatobiliary_system | 0.99467399 |
| 71 | MP0003195_calcinosis | 0.99220839 |
| 72 | MP0001663_abnormal_digestive_system | 0.98880218 |
| 73 | MP0000858_altered_metastatic_potential | 0.97843720 |
| 74 | MP0004883_abnormal_blood_vessel | 0.96639581 |
| 75 | MP0000249_abnormal_blood_vessel | 0.92288344 |
| 76 | MP0000490_abnormal_crypts_of | 0.92212609 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 0.92172082 |
| 78 | MP0002933_joint_inflammation | 0.91790532 |
| 79 | MP0005390_skeleton_phenotype | 0.89163467 |
| 80 | MP0003763_abnormal_thymus_physiology | 0.88789912 |
| 81 | MP0009763_increased_sensitivity_to | 0.88205278 |
| 82 | MP0003566_abnormal_cell_adhesion | 0.86032204 |
| 83 | MP0002928_abnormal_bile_duct | 0.85735621 |
| 84 | MP0000604_amyloidosis | 0.81089614 |
| 85 | MP0000703_abnormal_thymus_morphology | 0.80514581 |
| 86 | MP0000767_abnormal_smooth_muscle | 0.77183079 |
| 87 | MP0005075_abnormal_melanosome_morpholog | 0.76537861 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.75768162 |
| 89 | MP0005164_abnormal_response_to | 0.75662866 |
| 90 | MP0006054_spinal_hemorrhage | 0.74891061 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.74720066 |
| 92 | MP0003866_abnormal_defecation | 0.74259588 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.73553859 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.73154606 |
| 95 | MP0001915_intracranial_hemorrhage | 0.73143237 |
| 96 | MP0004130_abnormal_muscle_cell | 0.71227236 |
| 97 | MP0008007_abnormal_cellular_replicative | 0.71106693 |
| 98 | MP0003795_abnormal_bone_structure | 0.70746263 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.70727913 |
| 100 | MP0002090_abnormal_vision | 0.68628728 |
| 101 | MP0005535_abnormal_body_temperature | 0.65985068 |
| 102 | MP0005670_abnormal_white_adipose | 0.65417708 |
| 103 | MP0003646_muscle_fatigue | 0.63073905 |
| 104 | MP0002132_abnormal_respiratory_system | 0.62906130 |
| 105 | MP0005409_darkened_coat_color | 0.62102447 |
| 106 | MP0002075_abnormal_coat/hair_pigmentati | 0.61768096 |
| 107 | MP0009115_abnormal_fat_cell | 0.61561641 |
| 108 | MP0005257_abnormal_intraocular_pressure | 0.61461211 |
| 109 | MP0000920_abnormal_myelination | 0.61079595 |
| 110 | MP0003252_abnormal_bile_duct | 0.60904592 |
| 111 | MP0008873_increased_physiological_sensi | 0.59671314 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.59075431 |
| 113 | MP0003279_aneurysm | 0.58265735 |
| 114 | MP0005365_abnormal_bile_salt | 0.57966991 |
| 115 | MP0005334_abnormal_fat_pad | 0.57364421 |
| 116 | MP0008260_abnormal_autophagy | 0.55805776 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.54290773 |
| 118 | MP0005165_increased_susceptibility_to | 0.52620385 |
| 119 | MP0003638_abnormal_response/metabolism_ | 0.51830374 |
| 120 | MP0005381_digestive/alimentary_phenotyp | 0.51391700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.79454352 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 6.61622782 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.40505950 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.40775100 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.39458617 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.39458617 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.39458617 |
| 8 | Glomerulonephritis (HP:0000099) | 5.11655281 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 4.98967041 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.79116628 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 4.56020984 |
| 12 | Dysostosis multiplex (HP:0000943) | 4.28452177 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.26711259 |
| 14 | Recurrent skin infections (HP:0001581) | 3.96087831 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.94332644 |
| 16 | Myositis (HP:0100614) | 3.72093172 |
| 17 | Disinhibition (HP:0000734) | 3.70862740 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 3.48532161 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.40554602 |
| 20 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.36334652 |
| 21 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.36334652 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.36334652 |
| 23 | Complement deficiency (HP:0004431) | 3.34516505 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.29599552 |
| 25 | Mucopolysacchariduria (HP:0008155) | 3.29474861 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.29474861 |
| 27 | Obstructive lung disease (HP:0006536) | 3.22062736 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.22062736 |
| 29 | Gingivitis (HP:0000230) | 3.21379168 |
| 30 | Agnosia (HP:0010524) | 3.19618254 |
| 31 | Prostate neoplasm (HP:0100787) | 3.18273607 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.16242064 |
| 33 | Axonal loss (HP:0003447) | 3.15355534 |
| 34 | Retinal atrophy (HP:0001105) | 3.13533691 |
| 35 | Encephalitis (HP:0002383) | 3.13024751 |
| 36 | Orchitis (HP:0100796) | 3.06885573 |
| 37 | Arterial tortuosity (HP:0005116) | 3.06647449 |
| 38 | Hematochezia (HP:0002573) | 3.06500207 |
| 39 | Abnormality of B cell number (HP:0010975) | 3.06303218 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 3.03656975 |
| 41 | Agammaglobulinemia (HP:0004432) | 2.97534968 |
| 42 | Colitis (HP:0002583) | 2.96253779 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 2.95009210 |
| 44 | Optic neuritis (HP:0100653) | 2.95009210 |
| 45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.85987859 |
| 46 | Hemoptysis (HP:0002105) | 2.83997509 |
| 47 | Recurrent viral infections (HP:0004429) | 2.83579209 |
| 48 | Increased IgE level (HP:0003212) | 2.81680097 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81283819 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81283819 |
| 51 | Basal ganglia calcification (HP:0002135) | 2.78075280 |
| 52 | Abnormality of complement system (HP:0005339) | 2.77455479 |
| 53 | B lymphocytopenia (HP:0010976) | 2.77422685 |
| 54 | Hepatosplenomegaly (HP:0001433) | 2.75541282 |
| 55 | Nephritis (HP:0000123) | 2.75473050 |
| 56 | J-shaped sella turcica (HP:0002680) | 2.75137688 |
| 57 | T lymphocytopenia (HP:0005403) | 2.70171120 |
| 58 | Mutism (HP:0002300) | 2.66860328 |
| 59 | Chronic diarrhea (HP:0002028) | 2.65257013 |
| 60 | Inflammation of the large intestine (HP:0002037) | 2.63812962 |
| 61 | Stomatitis (HP:0010280) | 2.63545812 |
| 62 | Periodontitis (HP:0000704) | 2.63129689 |
| 63 | Urethral obstruction (HP:0000796) | 2.62554223 |
| 64 | Abnormality of T cell number (HP:0011839) | 2.60734170 |
| 65 | Vascular tortuosity (HP:0004948) | 2.58965246 |
| 66 | Upper motor neuron abnormality (HP:0002127) | 2.57522473 |
| 67 | Amyloidosis (HP:0011034) | 2.56126821 |
| 68 | Granulocytopenia (HP:0001913) | 2.55719534 |
| 69 | Keratoconjunctivitis sicca (HP:0001097) | 2.54678991 |
| 70 | Pustule (HP:0200039) | 2.50229389 |
| 71 | Gastrointestinal infarctions (HP:0005244) | 2.50206048 |
| 72 | Cellulitis (HP:0100658) | 2.48444445 |
| 73 | Abnormality of T cells (HP:0002843) | 2.48323110 |
| 74 | Combined immunodeficiency (HP:0005387) | 2.48057447 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.47636196 |
| 76 | Keratoconjunctivitis (HP:0001096) | 2.47172499 |
| 77 | Thick nail (HP:0001805) | 2.46181799 |
| 78 | Spondylolisthesis (HP:0003302) | 2.46131313 |
| 79 | Abnormal platelet function (HP:0011869) | 2.45896846 |
| 80 | Impaired platelet aggregation (HP:0003540) | 2.45896846 |
| 81 | Meningitis (HP:0001287) | 2.45571076 |
| 82 | Pathologic fracture (HP:0002756) | 2.44540477 |
| 83 | Cerebral aneurysm (HP:0004944) | 2.43994844 |
| 84 | Thoracic kyphosis (HP:0002942) | 2.40587068 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.39820802 |
| 86 | Vasculitis (HP:0002633) | 2.37563026 |
| 87 | Loss of speech (HP:0002371) | 2.37388933 |
| 88 | Autoimmune thrombocytopenia (HP:0001973) | 2.36917758 |
| 89 | Increased serum ferritin (HP:0003281) | 2.36907580 |
| 90 | Gastrointestinal inflammation (HP:0004386) | 2.35715998 |
| 91 | Osteomyelitis (HP:0002754) | 2.34846738 |
| 92 | Prolonged bleeding time (HP:0003010) | 2.31060286 |
| 93 | Epistaxis (HP:0000421) | 2.28041726 |
| 94 | Purpura (HP:0000979) | 2.27777889 |
| 95 | Abnormality of the prostate (HP:0008775) | 2.27029673 |
| 96 | Recurrent pneumonia (HP:0006532) | 2.26400890 |
| 97 | Autoimmune hemolytic anemia (HP:0001890) | 2.24786384 |
| 98 | Progressive neurologic deterioration (HP:0002344) | 2.23811241 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 2.23393027 |
| 100 | Chest pain (HP:0100749) | 2.23190241 |
| 101 | Abnormality of T cell physiology (HP:0011840) | 2.23144550 |
| 102 | Increased IgM level (HP:0003496) | 2.22145115 |
| 103 | Arterial thrombosis (HP:0004420) | 2.18227689 |
| 104 | Pulmonary embolism (HP:0002204) | 2.15304339 |
| 105 | Eosinophilia (HP:0001880) | 2.14521916 |
| 106 | Hypergammaglobulinemia (HP:0010702) | 2.13179166 |
| 107 | Leukocytosis (HP:0001974) | 2.13014210 |
| 108 | Pulmonary infiltrates (HP:0002113) | 2.12638955 |
| 109 | Polyneuropathy (HP:0001271) | 2.11983306 |
| 110 | Petechiae (HP:0000967) | 2.10748327 |
| 111 | Gingival bleeding (HP:0000225) | 2.10254560 |
| 112 | Spontaneous hematomas (HP:0007420) | 2.08941475 |
| 113 | Abnormality of the pleura (HP:0002103) | 2.07651185 |
| 114 | Abnormality of eosinophils (HP:0001879) | 2.05696305 |
| 115 | Progressive visual loss (HP:0000529) | 2.04673002 |
| 116 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03319880 |
| 117 | Thrombocytosis (HP:0001894) | 2.03209980 |
| 118 | Abnormality of the thoracic spine (HP:0100711) | 2.02504233 |
| 119 | Bone pain (HP:0002653) | 2.02386069 |
| 120 | Inappropriate behavior (HP:0000719) | 2.01245221 |
| 121 | IgM deficiency (HP:0002850) | 2.00642129 |
| 122 | Joint hemorrhage (HP:0005261) | 2.00304157 |
| 123 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.96324742 |
| 124 | Gangrene (HP:0100758) | 1.95051667 |
| 125 | Chronic otitis media (HP:0000389) | 1.92142901 |
| 126 | Interstitial pulmonary disease (HP:0006530) | 1.91867004 |
| 127 | Sepsis (HP:0100806) | 1.90952087 |
| 128 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89869284 |
| 129 | Osteolytic defects of the hand bones (HP:0009699) | 1.89869284 |
| 130 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.88603279 |
| 131 | Vertigo (HP:0002321) | 1.87754501 |
| 132 | Abnormality of the lumbar spine (HP:0100712) | 1.86672599 |
| 133 | Urticaria (HP:0001025) | 1.86254575 |
| 134 | Recurrent lower respiratory tract infections (HP:0002783) | 1.85752106 |
| 135 | Striae distensae (HP:0001065) | 1.85464038 |
| 136 | Aortic aneurysm (HP:0004942) | 1.82912824 |
| 137 | Deformed sella turcica (HP:0002681) | 1.82905615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 6.11689448 |
| 2 | GRK7 | 3.40417234 |
| 3 | IRAK4 | 3.28739174 |
| 4 | RIPK4 | 3.11087756 |
| 5 | BLK | 3.03459501 |
| 6 | TYK2 | 2.93936923 |
| 7 | IRAK3 | 2.90661562 |
| 8 | CSF1R | 2.85809654 |
| 9 | KIT | 2.76597532 |
| 10 | MAP4K1 | 2.42252777 |
| 11 | MAP3K14 | 2.36301211 |
| 12 | TBK1 | 2.28952593 |
| 13 | TXK | 2.15408802 |
| 14 | MAP2K3 | 2.07344985 |
| 15 | CAMK1D | 1.95295088 |
| 16 | MAPK15 | 1.94817129 |
| 17 | JAK1 | 1.93169543 |
| 18 | ZAP70 | 1.82183172 |
| 19 | ACVR1B | 1.81266049 |
| 20 | IKBKB | 1.77270941 |
| 21 | IKBKE | 1.76677304 |
| 22 | TEC | 1.71837444 |
| 23 | MAP3K11 | 1.69800394 |
| 24 | NME2 | 1.64883386 |
| 25 | STK10 | 1.62043021 |
| 26 | HCK | 1.55512861 |
| 27 | FES | 1.54430003 |
| 28 | GRK6 | 1.54329482 |
| 29 | TAOK3 | 1.53545426 |
| 30 | ITK | 1.51943216 |
| 31 | BTK | 1.40275875 |
| 32 | JAK3 | 1.38687919 |
| 33 | CAMK1G | 1.37810489 |
| 34 | CLK1 | 1.35248734 |
| 35 | SYK | 1.34251704 |
| 36 | CSK | 1.31831270 |
| 37 | EIF2AK2 | 1.30700623 |
| 38 | MATK | 1.26122771 |
| 39 | * LYN | 1.25187802 |
| 40 | DAPK2 | 1.20987267 |
| 41 | ADRBK2 | 1.20916339 |
| 42 | TLK1 | 1.20554475 |
| 43 | LCK | 1.15749805 |
| 44 | NEK9 | 1.15220634 |
| 45 | CAMKK2 | 1.11610852 |
| 46 | RPS6KA4 | 1.05642128 |
| 47 | MAP3K13 | 1.04419881 |
| 48 | CDK3 | 1.04271968 |
| 49 | PRPF4B | 1.03208703 |
| 50 | TGFBR1 | 0.97712812 |
| 51 | MAP3K6 | 0.96779313 |
| 52 | JAK2 | 0.95169713 |
| 53 | MAPK7 | 0.94649787 |
| 54 | TESK2 | 0.92321480 |
| 55 | YES1 | 0.91393200 |
| 56 | TAOK1 | 0.89597148 |
| 57 | MAPK12 | 0.88658511 |
| 58 | BCKDK | 0.86313308 |
| 59 | CDC42BPA | 0.84684575 |
| 60 | PAK4 | 0.84026285 |
| 61 | MAP2K6 | 0.83670991 |
| 62 | ABL2 | 0.82980975 |
| 63 | CHUK | 0.82564322 |
| 64 | MOS | 0.81422885 |
| 65 | TRPM7 | 0.79673400 |
| 66 | PIK3CG | 0.74408330 |
| 67 | SIK2 | 0.73236171 |
| 68 | FRK | 0.71276619 |
| 69 | FGR | 0.69130473 |
| 70 | CDK6 | 0.68776491 |
| 71 | CDK8 | 0.68756181 |
| 72 | ERN1 | 0.67690621 |
| 73 | MAP3K1 | 0.67255781 |
| 74 | TAOK2 | 0.67170303 |
| 75 | TNIK | 0.65681018 |
| 76 | HIPK2 | 0.62485562 |
| 77 | BMPR1B | 0.62441550 |
| 78 | CAMK4 | 0.59476065 |
| 79 | KDR | 0.55185175 |
| 80 | MAPKAPK2 | 0.54372159 |
| 81 | MARK3 | 0.53075574 |
| 82 | CDK12 | 0.52651858 |
| 83 | PIM1 | 0.52170639 |
| 84 | PDK1 | 0.52090422 |
| 85 | PRKD2 | 0.51806889 |
| 86 | EGFR | 0.51401970 |
| 87 | IGF1R | 0.51198196 |
| 88 | MAP3K3 | 0.50833636 |
| 89 | PDPK1 | 0.50497761 |
| 90 | FGFR3 | 0.48853219 |
| 91 | VRK1 | 0.48169486 |
| 92 | PRKCD | 0.46227945 |
| 93 | EPHB1 | 0.45648909 |
| 94 | TSSK6 | 0.44123371 |
| 95 | MAP2K2 | 0.43330296 |
| 96 | CAMKK1 | 0.42989479 |
| 97 | CDK4 | 0.42947905 |
| 98 | STK4 | 0.41596900 |
| 99 | MAPKAPK5 | 0.41405927 |
| 100 | FLT3 | 0.40077211 |
| 101 | IRAK1 | 0.39926965 |
| 102 | ABL1 | 0.39166156 |
| 103 | SGK3 | 0.38457875 |
| 104 | MARK2 | 0.38341323 |
| 105 | PIM2 | 0.37220176 |
| 106 | EEF2K | 0.34094431 |
| 107 | ADRBK1 | 0.34022472 |
| 108 | RPS6KA6 | 0.33295679 |
| 109 | BMPR2 | 0.33004366 |
| 110 | ZAK | 0.32769088 |
| 111 | MAPK11 | 0.31674759 |
| 112 | MAPK4 | 0.30837806 |
| 113 | SGK2 | 0.29468564 |
| 114 | MAPK3 | 0.28658105 |
| 115 | PRKAA2 | 0.27791935 |
| 116 | EPHA3 | 0.26399090 |
| 117 | RPS6KC1 | 0.26147697 |
| 118 | RPS6KL1 | 0.26147697 |
| 119 | PRKCQ | 0.26041929 |
| 120 | PDK2 | 0.25864599 |
| 121 | RPS6KA2 | 0.25781568 |
| 122 | BRD4 | 0.25718958 |
| 123 | FYN | 0.25102475 |
| 124 | TNK2 | 0.24828802 |
| 125 | GRK5 | 0.23575210 |
| 126 | SIK3 | 0.22110547 |
| 127 | MAP3K5 | 0.21725057 |
| 128 | IRAK2 | 0.20939461 |
| 129 | CAMK1 | 0.20162145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.00412297 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.94036239 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.50744832 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.98871728 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.89942616 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.82904812 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.45683013 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.42248444 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.26947046 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.23641966 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21144048 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.03511047 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.01761119 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 2.01061918 |
| 15 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.85567701 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.82239158 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.81122276 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.77366091 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.69982671 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68985633 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68546428 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 1.55328767 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.55282165 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54300344 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53706315 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51067006 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.49283757 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46762592 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42609954 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42483060 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.34264628 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.31637631 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27749094 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25901410 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.20247459 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19998732 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.14152410 |
| 38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.10333478 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10217021 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07488460 |
| 41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.04259257 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04093848 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.03760262 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.03399966 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00432790 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98062101 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96756760 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95962925 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.93417885 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 0.92341415 |
| 51 | Asthma_Homo sapiens_hsa05310 | 0.89314813 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84285104 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.83800629 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.82514165 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81283378 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78998330 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78592548 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.78336647 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78169868 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75511476 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.75472931 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75172825 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73054034 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71441206 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70599722 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68150364 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67912091 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66971207 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62541221 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61675147 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60279886 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60138844 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.59947366 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57133342 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50934640 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.50424900 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49958138 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49136296 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48383176 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45859597 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43055342 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42855668 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42086609 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41395557 |
| 85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40920938 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.40508160 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39672361 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38513759 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35940367 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35546918 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34647415 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33456427 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33294591 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31040868 |
| 95 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.30887464 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30389280 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.30147160 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30146278 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30002532 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.29661075 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28610168 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28468426 |
| 103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.28345763 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28102087 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27774332 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27435808 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26093191 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24442318 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23539556 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22394997 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22156049 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.21899241 |
| 113 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.21308556 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19820412 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.18965553 |
| 116 | Bladder cancer_Homo sapiens_hsa05219 | 0.17262177 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16688244 |
| 118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.16221974 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.16172940 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.14589677 |
| 121 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.11717671 |

